Laine, K <br/><br/>
No sex-related differences but significant inhibition by oral contraceptives of CYP2C19 activity as measured by the probe drugs mephenytoin and omeprazole in healthy Swedish white subjects.  [electronic resource] 

 -  Clinical pharmacology and therapeutics  Aug 2000 
 - 151-9 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>0009-9236 
<br/><br/><label>Standard No.: </label>10.1067/mcp.2000.108949  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adolescent<br/>Adult<br/>Aged<br/>Anticonvulsants--blood<br/>Aryl Hydrocarbon Hydroxylases<br/>Contraceptives, Oral--pharmacology<br/>Cytochrome P-450 CYP2C19<br/>Cytochrome P-450 Enzyme Inhibitors<br/>Cytochrome P-450 Enzyme System--metabolism<br/>Drug Interactions<br/>Enzyme Inhibitors--blood<br/>Female<br/>Humans<br/>Mephenytoin--blood<br/>Middle Aged<br/>Mixed Function Oxygenases--antagonists & inhibitors<br/>Omeprazole--blood<br/>Sex Characteristics<br/>Sweden<br/>White People